2012 Feb 8 – FDA Drug Safety Communication: PPI – Clostridium Difficile Associated Diarrhea

FDA Drug safety communication
U.S. Food and Drug Administration (FDA) is informing the public that the use of stomach acid drugs known as proton pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile – associated diarrhea (CDAD)…

FDA link